News

MCHP heads into fiscal Q1 2027 with stronger bookings, AI and data center demand, channel restocking and expected margin expansion.

Lemonade's Q2 revenues surged 79% as premiums and loss ratio improved, but its rich valuation and softer estimates make the stock a hold.

Tower Semiconductor (NASDAQ:TSEM) reported record second-quarter 2026 revenue and profitability, citing accelerating demand for silicon photonics and related data-center connectivity products. The company also raised its 2028 financial model and detailed a two-track expansion plan in Japan intended

Sterling Infrastructure (NASDAQ:STRL) reported sharply higher second-quarter results as demand for mission-critical infrastructure work, including data centers and semiconductor campuses, drove growth in its E-Infrastructure Solutions segment. Management also raised its full-year outlook to reflect

Long-term investors should focus on SpaceX's lockup expiration on Thursday.

Ericsson posts stronger margins despite weaker revenues, highlighting disciplined execution as investors assess the path to renewed growth.

Investing.com -- Jefferies downgraded Cigna to Hold from Buy, arguing that a growing list of earnings headwinds and limited catalysts outweigh the stock's discounted valuation, while cutting its price target to $307 from $336.

Applied Optoelectronics heads into Q2 earnings with AI-driven 800G demand and CATV growth, but valuation and production constraints loom.

Merck beat Q2 earnings and sales estimates as strong oncology and newer products lift results, prompting the company to raise and narrow its 2026 sales outlook.

Jazz Pharmaceuticals tops Q2 sales estimates and raises its 2026 revenue outlook despite an EPS miss, as strong oncology and neuroscience demand lifts shares.

The Danish drugmaker's Wegovy pill has exceeded 5 million prescriptions in the U.S. since launch, driving stronger-than-expected profit

(Updates with index/price moves, macroeconomic data, and company news from the first paragraph.)

SNDK's fiscal Q4 top line may gain from surging AI data center demand and stronger edge sales tied to AI PCs and premium smartphones.

AST SpaceMobile heads into Q2 earnings with satellite launches, FCC approval and growth plans, but rising competition and execution risks keep investors cautious.

TLN heads into second-quarter results with sharply higher estimates, added gas-fired capacity and a strategy focused on locking in new power demand.

Airbus (ENXTPA:AIR) has put itself in focus after raising its 2029 adjusted EBIT guidance and launching a €5.8b share buyback program, alongside reporting higher second quarter sales and net income. See our latest analysis for Airbus. The recent guidance upgrade, strong second quarter results and new orders, such as Philippine Airlines' A350-1000 agreement in July 2026, come as Airbus shares trade at €208.0 with a 90 day share price return of 10.34% and a 5 year total shareholder return of...

Nvidia stock clears the 50-day moving average amid Big Tech earnings. Advanced Micro Devices is set to report Tuesday.

ODFL's Q2 earnings beat, margin gains and $380 million spending plan signal growth potential, though demand recovery will shape capacity returns.

MP Materials faces Q2 earnings with strong production growth but a negative Earnings ESP. Can expanding rare earth operations outweigh higher costs?

UUUU heads into Q2 earnings with revenues expected to surge on higher uranium sales, even as it is projected to post another quarterly loss.

Powell Industries (NASDAQ:POWL) reported record third-quarter order bookings and a backlog that surpassed $2 billion for the first time in its 79-year history, as demand remained strong across data centers, electric utilities, LNG and other industrial markets. For the fiscal third quarter ended Jun

The Danish drugmaker said annual sales and operating profit should fall less than it previously expected following a boost in the second quarter.

FTI tops Q2 earnings and revenue estimates as Subsea strength lifts margins and sales, while reaffirming full-year 2026 guidance and shareholder returns.

PBR heads into Q2 earnings with strong production growth, but fuel pricing, refinery maintenance and higher spending could test results.

INSP beats second-quarter estimates, raises its 2026 outlook and sees shares jump despite U.S. reimbursement pressures and lower revenues.

Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics and medical devices businesses helped ease investor concerns surrounding procedure volumes. Sales for the quarter rose 13% on a reported basis and 4.8% on a comparable basis. Danaher Corporation’s (NYSE:DHR) […]

MCD's Q2 earnings beat estimates as stronger franchised margins offset a revenue miss, while comparable sales rise across all three segments.

GRAB's second-quarter 2026 revenues benefit from growth across its On-Demand and Financial Services segments.

PENN's Q2 results are likely to reflect stable retail gaming demand and Interactive momentum, offset by Aurora closure and macro pressures.

Moby summary of Superior Group of Companies, Inc.'s Q2 2026 earnings call